Taken together, these data suggest that BMP modulation could be an attractive target in CRC metastasis and that leveraging hepatocytes to augment BMP signaling by AAV8-Islr could represent an exciting, novel therapeutic opportunity in metastatic CRC. Here, ISLR is linked to colorectal carcinoma.